Cargando…

[(68)Ga]Ga-FAPI-04 PET MRI/CT in the evaluation of gastric carcinomas compared with [(18)F]-FDG PET MRI/CT: a meta-analysis

OBJECTIVES: To compare the detection rates of [(68)Ga]Ga-FAPI-04 PET MRI/CT vs. [(18)F]-FDG PET MRI/CT in gastric cancer. METHODS: An extensive librarian-led literature search of PubMed, Embase, Web of Science, the Cochrane Central Library, and ClinicalTrials.gov was performed. The primary outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yawen, Luo, Wenhao, Li, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847115/ https://www.ncbi.nlm.nih.gov/pubmed/36653862 http://dx.doi.org/10.1186/s40001-023-00997-9

Ejemplares similares

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer
por: Du, Tao, et al.
Publicado: (2023)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Comparison of Diagnostic Efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT for Staging and Restaging of Gastric Cancer
por: Zhang, Shumao, et al.
Publicado: (2022)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

Head-to-head comparison of [(68)Ga]Ga-FAPI-04 and [(18)F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma
por: Kuten, Jonathan, et al.
Publicado: (2021)

Utility of [(68)Ga]FAPI-04 and [(18)F]FDG dual-tracer PET/CT in the initial evaluation of gastric cancer
por: Miao, Ying, et al.
Publicado: (2022)

Prospective comparison of (68)Ga-FAPI-04 and (18)F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma
por: Ding, Haoyuan, et al.
Publicado: (2022)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

Head-to-head evaluation of [(18)F]FDG and [(68) Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma
por: Gu, Bingxin, et al.
Publicado: (2022)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021)

(68)Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis
por: Tatar, Gamze, et al.
Publicado: (2023)

FAPI-04 Uptake in Healthy Tissues of Cancer Patients in (68)Ga-FAPI-04 PET/CT Imaging
por: Gündoğan, Cihan, et al.
Publicado: (2021)

(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
por: Wegen, Simone, et al.
Publicado: (2023)

A systematic review of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT in the diagnostic value of malignant tumor bone metastasis
por: Li, Lanying, et al.
Publicado: (2022)

Localization of Pyelonephritis by (68)Ga-FAPI PET CT
por: Jagtap, Rajlaxmi Rangrao, et al.
Publicado: (2023)

Comparison of the Relative Diagnostic Performance of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
por: Wu, Junhao, et al.
Publicado: (2021)

Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT
por: Treutlein, Christoph, et al.
Publicado: (2022)

Superior Tumor Detection for (68)Ga-FAPI-46 Versus (18)F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
por: Pabst, Kim M., et al.
Publicado: (2023)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

Head-to-head comparison of (68)Ga-FAPI-04 PET/CT and (18)F-FDG PET/CT in the evaluation of primary digestive system cancer: a systematic review and meta-analysis
por: Ouyang, Jiqi, et al.
Publicado: (2023)

(68)Ga-FAPI-04 PET/MR is helpful in differential diagnosis of pancreatitis from pancreatic malignancy compared to (18)F-FDG PET/CT: a case report
por: Shou, Yi, et al.
Publicado: (2021)

Performance and Prospects of [(68)Ga]Ga-FAPI PET/CT Scans in Lung Cancer
por: Borgonje, Paula E., et al.
Publicado: (2022)

(68)Ga-FAPI and (18)F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor
por: Gu, Bingxin, et al.
Publicado: (2020)

(18)F-FDG and (68) Ga-FAPI PET/CT for the evaluation of periprosthetic joint infection and aseptic loosening in rabbit models
por: Wang, Yiqun, et al.
Publicado: (2022)

Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer
por: Novruzov, E., et al.
Publicado: (2022)

Head-to-Head Comparison between [(68)Ga]Ga-DOTA.SA.FAPi and [(18)F]F-FDG PET/CT Imaging in Patients with Breast Cancer
por: Ballal, Sanjana, et al.
Publicado: (2023)

(68)Ga-FAPI-PET/CT in patients with various gynecological malignancies
por: Dendl, Katharina, et al.
Publicado: (2021)

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [(18)F]F-FDG PET/CT in Patients with Liver Malignancies
por: Siripongsatian, Dheeratama, et al.
Publicado: (2022)

(68)Ga-DOTA-FAPI-04 PET/CT as a Promising Tool for Differentiating Ovarian Physiological Uptake: Preliminary Experience of Comparative Analysis With (18)F-FDG
por: Wang, Qixin, et al.
Publicado: (2021)

Pneumonia with Intense (68)Ga-FAPI Uptake Mimicking Metastasis on (68)Ga-FAPI PET/CT in a Patient with Rectal Cancer
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2023)

(68)Ga-PSMA PET/CT Versus (18)F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Impact of (68)Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
por: Kosmala, Aleksander, et al.
Publicado: (2023)

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A (68)Ga-FAPI-04 PET/CT Imaging Study
por: Wang, Jingnan, et al.
Publicado: (2023)

Findings of I-131 SPECT/CT, (18)F-FDG, and (68)Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma
por: Tatar, Gamze, et al.
Publicado: (2023)

Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET/CT in cancer patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

The Added Value of (68)Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with (18)F-FDG–Negative Findings
por: Gu, Bingxin, et al.
Publicado: (2022)

Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
por: Wu, Junhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3g4br6vg65sdc99eou7dp3rcjd